accountHere's an interesting look at the current state of the Alzheimer's field from Bloomberg. The current big hope is Wyeth (and Elan)'s bapineuzumab, which I last wrote about here
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Amyloid In Trouble: In The Pipeline
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
